Vanda Pharmaceuticals Inc. | Business Contracts

License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant (Filed With SEC on May 6, 2022)

Description of Securities of the registrant (Filed With SEC on February 24, 2022)

Fifth Amendment to Lease Agreement, dated April 11, 2019 (Filed With SEC on February 11, 2021)

Amended and Restated Employment Agreement, dated July 27, 2020, by and between Kevin Moran and the registrant (Filed With SEC on July 29, 2020)

Manufacturing Agreement, dated January 24, 2014, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to HETLIOZ (Filed With SEC on February 24, 2022)

Manufacturing Agreement, dated May 6, 2016, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to Fanapt (Filed With SEC on February 24, 2022)

Sixth Amendment to Lease Agreement, dated May 7, 2020, by and between Square 54 Office Owner LLC and the registrant (Filed With SEC on February 11, 2021)

Amended and Restated Employment Agreement, dated May 5, 2020, by and between Kevin Moran and the registrant (Filed With SEC on May 7, 2020)

Employment Agreement, dated July 3, 2019, by and between Aranthan "AJ" Jones II and the registrant (Filed With SEC on November 7, 2019)

Employment Agreement, dated August 5, 2019, by and between Joakim Wijkstrom and the registrant (Filed With SEC on November 7, 2019)

Vanda Pharmaceuticals Inc. (10)